Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients

Nephrology Dialysis Transplantation

Volumn 21, Issue 2, 2006, Pages 494-498

  Furuya, Ryuichi ^a   Odamaki, Mari ^b   Kumagai, Hiromichi ^b   Hishida, Akira ^c  

^a Iwata City Hospital   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; Dyslipidaemia; Icodextrin; Insulin resistance; Leptin; Peritoneal dialysis

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ATORVASTATIN; BETAXOLOL; CANDESARTAN; CHOLESTEROL; GLUCOSE; GUANABENZ; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICODEXTRIN; INSULIN; LEPTIN; LIPID; NIFEDIPINE; TRIACYLGLYCEROL;

ADULT; AGED; ANURIA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LONG TERM CARE; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; FEMALE; GLUCANS; GLUCOSE; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS;

EID: 31544454694     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi197     Document Type: Article

References (20)

1. Lameire N, Bernaert P, Lambert MC, Vijt D. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1994; 46 [Suppl 48]: S31-S38
2. Reilly MP, Iqbal N, Schutta M et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 3872-3878
3. Wallace AM, McMahon AD, Packard CJ et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104: 3052-3056
4. Okamoto Y, Kihara S, Ouchi N et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767-2770
5. Ouchi N, Kihara S, Funahashi T et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107: 671-674
6. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: A comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 2004; 43: 1047-1055
7. Pérez Fontán M, Rodríguez-Carmona A, Cordido F, García-Buela J. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: A comparative analysis. Am J Kidney Dis 1999; 34: 824-831
8. Amici G, Orrasch M, Da Rin G, Bocci C. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Adv Pert Dial 2001; 17: 80-83
9. Bredie SJH, Bosch FH, Demacker PNM, Stalenhoef AFH, van Leusen R. Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit Dial Int 2001; 21: 275-281
10. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45: 988-991
11. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599
12. Zoccali C, Mallamaci F, Tripepi G et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-141
13. Satoh N, Naruse M, Usui T et al. Leptin to adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 2004; 27: 2488-2490
14. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 2005; 20: 129-134
15. Yang WS, Lee WL, Funahashi T et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815-3819
16. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002; 290: 1084-1089
17. Kolaczynski JW, Nyce MR, Considine RV et al. Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996; 45: 699-701
18. Landt M, Parvin CA, Dagogo-Jack S, Bryant B, Coyne DW. Leptin elimination in hyperleptinemic peritoneal dialysis patients. Nephrol Dial Transplant 1999; 14: 732-737
19. Opatrna S, Opatrny K Jr, Racek J, Sefrna F. Effect of icodextrin-based dialysis solution on peritoneal leptin clearance. Perit Dial Int 2003; 23 :89-91
20. Heimbürger O, Lönnqvist F, Danielsson A, Nordenström J, Stenvinkel P. Serum immunoreactive leptin concentrations and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997; 8: 1423-1430